Drug Discovery & Development
Ymmunobio get ownership rights to NPTXR antibodies. Read more here: https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-t...
top of page
In The News
Pascal Kraft
- Jan 13
- 1 min
Fierce Biotech: Appointment of Michel Janicot
Michel Janicot will serve in the newly created position of chief development officer. https://www.fiercebiotech.com/biotech/chutes-ladder...
Pascal Kraft
- Jun 14, 2022
- 1 min
BioPharma Dive
Ymmunobio Signs Collaboration Agreement with YUMAB https://www.biopharmadive.com/press-release/20220614-ymmunobio-signs-collaboration-agr...
Pascal Kraft
- Apr 11, 2022
- 1 min
PharmTech
Ymmunobio AG Signs Patent Purchase Agreement with LeukoGmbH https://www.pharmtech.com/view/ymmunobio-ag-signs-patent-purchase-agreement-w...
bottom of page